Sabal Trust’s Allergan plc AGN Stock Holding History

Sabal Trust’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-1,934	Closed	-$325K	–	158
2019 Q3	$325K	Buy	+1,934	New	+$315K	0.03%	118
2015 Q2	–	Sell	-1,524	Closed	-$453K	–	113
2015 Q1	$453K	Buy	+1,524	New	+$434K	0.06%	77

Other funds holding AGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Sabal Trust's AGN Position: Q4 2019 in Review

Sabal Trust sold out of Allergan plc (AGN) in Q4 2019, closing a stake of 1,934 shares — an estimated $325K sold.

Sabal Trust first reported a position in AGN in Q1 2015 and held it in 2 quarters. The position peaked at $453K in Q1 2015. 957 funds tracked by Wall St. Rank hold AGN as of Q4 2019.

Sabal Trust reported no remaining Allergan plc position as of Q4 2019 after selling out during the quarter.
Sabal Trust sold 1,934 Allergan plc shares in Q4 2019, an estimated $325K.
Sabal Trust first reported a position in Allergan plc in Q1 2015 and held it in 2 quarters.
Sabal Trust's Allergan plc position peaked at $453K in Q1 2015.
957 funds tracked by Wall St. Rank held Allergan plc as of Q4 2019.

Based on Sabal Trust's 13F filing for Q4 2019, filed 14 Jan 2020.